MarketPulse

Belén Garijo

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Sanofi

Sanofi Appoints Physician Belén Garijo as CEO, Signals Strategic Pivot

Sanofi shareholders approve Belén Garijo as CEO effective May 1, 2026, authorizing €4.12 dividend and welcoming Orange's Christel Heydemann to board.
SNYcorporate governanceAnnual General Meeting
GlobeNewswire Inc.GlobeNewswire Inc.··Sanofi

Sanofi Names Belén Garijo as CEO, Signals Leadership Transition with Strategic Board Refresh

Sanofi's AGM appoints physician Belén Garijo as CEO effective May 1, 2026, approves €4.12 dividend and welcomes Orange's Heydemann to board.
SNYdividendcorporate governance